WASHINGTON DC (September 25, 2019) — Senate Finance Committee Chairman Chuck Grassley (R-IA) and Ranking Member Ron Wyden (D-OR) released the statutory text of the Prescription Drug Pricing Reduction Act (PDPRA), S2543. The text mirrors the chairman’s mark that passed the Finance Committee in July with a bipartisan, two-thirds majority.
“President Trump has called on Congress to work together on a bipartisan bill to lower prescription-drug prices. And there’s only one bipartisan bill in Congress to lower prescription-drug prices that’s passed the committee process. This is it. Making prescription-drugs more affordable consistently ranks as a top issue for Americans from every corner of the country. I encourage my colleagues on both sides of the aisle to come to the table and work with us to get a bill passed and signed into law.” Sen Grassley said.
“The American people have made it clear to Congress: The time to put the drug industry before patients is over. The cost of prescription-drugs is too high, and Congress must act. This bill creates real accountability for drug-makers and middlemen who have spent decades profiteering with the expectation that tax-payers and families will foot the bill. Half-measures that fail to crack down on these excesses are not enough: The Finance Committee bill would make a real difference for countless Americans struggling with high drug-costs. I hope the Senate will pass our bill soon and begin working with the House of Representatives to get a bill to the president’s desk,” Sen Wyden said.
The statutory text can be found HERE.
The committee report can be found HERE.
A section-by-section explanation of the legislation can be found HERE.
